RecruitingNCT07165210
Incidence of 106TBL Lymph Node Metastasis
A Prospective Observational Study of Left Tracheobronchial Lymph Node Metastasis in Patients With Esophageal Cancer
Sponsor
Fudan University
Enrollment
1,852 participants
Start Date
Jul 21, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
the study was to document the incidence of left tracheobronchial lymph node metastasis, and the risk factors of metastasis.
Eligibility
Min Age: 20 YearsMax Age: 85 Years
Inclusion Criteria3
- patients with esophageal squamous cell carcinoma
- clinical staging: cT1-4a N0/+ M0.
- no history of other malignancy.
Exclusion Criteria2
- esophageal cancer in the neck
- poor physical status to have esophagectomy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNo Intervention: Observational Cohort
no intervention was applied in this cohort
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07165210
Related Trials
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
NCT0669584521 locations
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT0644597243 locations
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
NCT0646994446 locations
DESTINY-PANTUMOUR04
NCT0712400015 locations
Mayo Clinic Upper Digestive Disease Survey
NCT025309831 location